Top 10 Pharma Companies from IW US 500 [SLIDESHOW]
Sept. 20, 2013
From revenues of $67 billion in 2012 for Johnson & Johnson, to $6 billion for Actavis Inc., pharma companies had a relatively strong showing last year, according to the IW 500.
From revenues of $67 billion in 2012 for Johnson & Johnson, to $6 billion for Actavis Inc., pharma companies had a relatively strong showing last year, according to the IW US 500.
